These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 32485781

  • 1. The Pharmacokinetics of Fluticasone Furoate Given Intranasally in Healthy Subjects Using an Ultra-Sensitive Analytical Assay.
    Bouhajib M, Tayab Z.
    Drug Res (Stuttg); 2020 Jul; 70(7):310-316. PubMed ID: 32485781
    [Abstract] [Full Text] [Related]

  • 2. Absolute bioavailability of intranasal fluticasone furoate in healthy subjects.
    Allen A, Down G, Newland A, Reynard K, Rousell V, Salmon E, Scott R.
    Clin Ther; 2007 Jul; 29(7):1415-20. PubMed ID: 17825692
    [Abstract] [Full Text] [Related]

  • 3. Long-term safety of fluticasone furoate nasal spray in adults and adolescents with perennial allergic rhinitis.
    Rosenblut A, Bardin PG, Muller B, Faris MA, Wu WW, Caldwell MF, Fokkens WJ.
    Allergy; 2007 Sep; 62(9):1071-7. PubMed ID: 17686110
    [Abstract] [Full Text] [Related]

  • 4. An evaluation of the pharmacokinetics of tiotropium following a single-dose inhalation in healthy subjects using an ultra-sensitive bioanalytical method.
    Bouhajib M, Tayab Z.
    Drug Dev Ind Pharm; 2019 Dec; 45(12):1915-1920. PubMed ID: 31613148
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics, Safety, and Tolerability of Once-Daily Intranasal Fluticasone Furoate and Levocabastine Administered Alone or Simultaneously as fluticasone Furoate/Levocabastine Fixed-Dose Combination.
    Allen A, Murdoch RD, Bareille P, Burns O, Hughes S, Gupta A, Miller SR.
    Clin Pharmacol Drug Dev; 2016 May; 5(3):225-31. PubMed ID: 27163502
    [Abstract] [Full Text] [Related]

  • 6. Optimal dose selection of fluticasone furoate nasal spray for the treatment of seasonal allergic rhinitis in adults and adolescents.
    Martin BG, Ratner PH, Hampel FC, Andrews CP, Toler T, Wu W, Faris MA, Philpot EE.
    Allergy Asthma Proc; 2007 May; 28(2):216-25. PubMed ID: 17479608
    [Abstract] [Full Text] [Related]

  • 7. Preferences of adult patients with allergic rhinitis for the sensory attributes of fluticasone furoate versus fluticasone propionate nasal sprays: a randomized, multicenter, double-blind, single-dose, crossover study.
    Meltzer EO, Stahlman JE, Leflein J, Meltzer S, Lim J, Dalal AA, Prillaman BA, Philpot EE.
    Clin Ther; 2008 Feb; 30(2):271-9. PubMed ID: 18343265
    [Abstract] [Full Text] [Related]

  • 8. Effect of fluticasone propionate nasal spray on bioavailability of intranasal hydromorphone hydrochloride in patients with allergic rhinitis.
    Davis GA, Rudy AC, Archer SM, Wermeling DP, McNamara PJ.
    Pharmacotherapy; 2004 Jan; 24(1):26-32. PubMed ID: 14740785
    [Abstract] [Full Text] [Related]

  • 9. Pharmacodynamics and pharmacokinetics of fluticasone furoate/vilanterol in healthy Chinese subjects.
    Chen X, Zheng X, Jiang J, Hu P, Wu K, Zhuang L, Liu L, Du X, Kempsford R, Allen A.
    Pharmacotherapy; 2015 Jun; 35(6):586-99. PubMed ID: 26059225
    [Abstract] [Full Text] [Related]

  • 10. A review of the pharmacology and pharmacokinetics of inhaled fluticasone propionate and mometasone furoate.
    Crim C, Pierre LN, Daley-Yates PT.
    Clin Ther; 2001 Sep; 23(9):1339-54. PubMed ID: 11589253
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of Intranasal Corticosteroid Sensory Attributes and Patient Preference for Fluticasone Furoate for the Treatment of Allergic Rhinitis.
    May JR, Dolen WK.
    Clin Ther; 2019 Aug; 41(8):1589-1596. PubMed ID: 31402060
    [Abstract] [Full Text] [Related]

  • 12. A randomized, crossover study to investigate the pharmacokinetics and safety of inhaled fluticasone furoate and umeclidinium, administered separately and in combination via dry powder inhaler in healthy adult volunteers.
    Yang S, Lee L, Mallett S, Ayer J, Wolstenholme A, Pascoe S.
    Adv Ther; 2015 Feb; 32(2):157-71. PubMed ID: 25700806
    [Abstract] [Full Text] [Related]

  • 13. Salmeterol and fluticasone propionate given as a combination. Lack of systemic pharmacodynamic and pharmacokinetic interactions.
    Kirby S, Falcoz C, Daniel MJ, Milleri S, Squassante L, Ziviani L, Ventresca GP.
    Eur J Clin Pharmacol; 2001 Feb; 56(11):781-91. PubMed ID: 11294367
    [Abstract] [Full Text] [Related]

  • 14. Bioavailability of fluticasone propionate and mometasone furoate aqueous nasal sprays.
    Daley-Yates PT, Kunka RL, Yin Y, Andrews SM, Callejas S, Ng C.
    Eur J Clin Pharmacol; 2004 Jun; 60(4):265-8. PubMed ID: 15114430
    [Abstract] [Full Text] [Related]

  • 15. A 2-week, crossover study to investigate the effect of fluticasone furoate nasal spray on short-term growth in children with allergic rhinitis.
    Gradman J, Caldwell MF, Wolthers OD.
    Clin Ther; 2007 Aug; 29(8):1738-47. PubMed ID: 17919555
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetic Comparison of a Unit Dose Dry Powder Inhaler with a Multidose Dry Powder Inhaler for Delivery of Fluticasone Furoate.
    Mehta R, Moore A, Riddell K, Joshi S, Chan R.
    J Aerosol Med Pulm Drug Deliv; 2017 Oct; 30(5):332-338. PubMed ID: 28463040
    [Abstract] [Full Text] [Related]

  • 17. Comparison of patient preference for sensory attributes of fluticasone furoate or fluticasone propionate in adults with seasonal allergic rhinitis: a randomized, placebo-controlled, double-blind study.
    Meltzer EO, Andrews C, Journeay GE, Lim J, Prillaman BA, Garris C, Philpot E.
    Ann Allergy Asthma Immunol; 2010 Apr; 104(4):331-8. PubMed ID: 20408344
    [Abstract] [Full Text] [Related]

  • 18. Open-Label, Crossover Study to Determine the Pharmacokinetics of Fluticasone Furoate and Batefenterol When Administered Alone, in Combination, or Concurrently.
    Ambery C, Young G, Fuller T, Georgiou A, Ramsay D, Puri A, Daley-Yates P.
    Clin Pharmacol Drug Dev; 2019 Feb; 8(2):188-197. PubMed ID: 30070770
    [Abstract] [Full Text] [Related]

  • 19. Open-Label, Randomized, 6-Way Crossover, Single-Dose Study to Determine the Pharmacokinetics of Batefenterol (GSK961081) and Fluticasone Furoate When Administered Alone or in Combination.
    Ambery C, Riddell K, Daley-Yates P.
    Clin Pharmacol Drug Dev; 2016 Sep; 5(5):399-407. PubMed ID: 27170445
    [Abstract] [Full Text] [Related]

  • 20. The pharmacodynamics, pharmacokinetics, safety and tolerability of inhaled fluticasone furoate and vilanterol administered alone or simultaneously as fluticasone furoate/vilanterol.
    Kempsford R, Allen A, Bareille P, Hamilton M, Cheesbrough A.
    Clin Pharmacol Drug Dev; 2015 Jan; 4(1):2-11. PubMed ID: 27127998
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.